With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

After a record-breaking year for startup IPOs in 2025, the momentum for new-age tech companies going for public listings appears even stronger in 2026 Twenty four startups have already filed their ...

President Donald Trump is rebuilding his tariff wall around the US economy, saying the import taxes are needed to combat unfair trading practices and safeguard national security. Shortly after the ...